Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Health Catalyst, Inc Common Stock | HCAT

Daily Technical Analysis of Health Catalyst, Inc Common Stock

Health Catalyst had a rough day and is now down -7.13%. Investors weren't too impressed with the future outlook for the asset which caused some selling on weak demand.

Health Catalyst doesn't seem to be at a very clear reversal point in either direction. Momentum wise Health Catalyst, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. HCAT might find some support at the 6.47 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Health Catalyst By Price Target And Rating

The balance of viewpoints by the analysts is positive. The current Analysts Sentiment Score is 69.10. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. KeyCorp provided a price target decease of -16.67% to $10.00 from $12.00 on 2024-02-26. On 2024-02-23 Canaccord Genuity Group lowered their price target by -8.33% to $11.00. Evercore ISI provided a price target decease of -9.09% to $10.00 from $11.00 on 2024-02-23. Piper Sandler reiterated a rating of Overweight on 2024-02-23 and decided to decrease their price target by -11.76% down to $15.00. Guggenheim upgraded from Neutral to Buy on 2024-01-26 and they set their price target at $14.00. Barclays initiated a rating of Overweight on 2024-01-03 and provided a price target of $14.00. JPMorgan Chase & Co. announced an upgrade on 2023-12-13 from Neutral to Overweight but dropped their 1 year price target to $11.00 which is down from $14.00. On 2023-11-01 Stifel Nicolaus lowered their price target by -20% to $12.00. Royal Bank of Canada announced a lowering of their price target to $8.00 from $13.00 on 2023-10-30. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-09-14 and they set their price target at $16.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
HCAT69.10146.79-2.0165.76-72.34

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-16)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
HCAT0.000.00

Short interest for Health Catalyst

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
HCAT3.38%2.28233.238.941300000

Social Sentiment for Health Catalyst

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
HCAT

Companies with the highest correlation to Health Catalyst

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
PHR | Phreesia, Inc.1.28-6.18-5.14-13.98-19.2154.31-34.61263.395.6913.40-21228.27-2822.42004.24586
TDOC | Teladoc Health, Inc.1.24-3.202.39-11.99-31.60-23.66-48.4343-24.98-33.71-40.36-27887.95-843.48008.78425
VRNS | Varonis Systems, Inc.1.14-0.453.07-5.30-0.4742.3590.4939235.39146.05187.64-2197.91163.30005.39701
CSTL | Castle Biosciences, Inc. 1.11-1.761.04-11.92-15.4754.11-11.92253.2910.7112.28-4312.66-350.98004.79274
QTRX | Quanterix Corporation Com1.11-0.870.44-32.51-28.02-24.6434.40458.6416.4335.00-1797.53-27566.83002.50203
TXG | 10x Genomics, Inc. Class 1.11-3.85-5.30-29.50-36.50-28.53-48.178-13.60-12.66-11.64-20764.54-2252.5101258.00406
STAA | Staar Surgical Co1.11-3.38-0.4020.7064.9519.17-31.6569-10.25-29.14-44.31-39151.64-4088.9112509.22466

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-